PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 133 filers reported holding PDL BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $10,000 | +42.9% | 3,226 | +25.3% | 0.00% | – |
| Q1 2020 | $7,000 | +16.7% | 2,574 | +39.7% | 0.00% | – |
| Q4 2019 | $6,000 | +50.0% | 1,842 | +17.0% | 0.00% | – |
| Q3 2019 | $4,000 | -55.6% | 1,574 | -41.9% | 0.00% | – |
| Q2 2019 | $9,000 | +50.0% | 2,708 | +71.9% | 0.00% | – |
| Q1 2019 | $6,000 | +20.0% | 1,575 | +0.1% | 0.00% | – |
| Q4 2018 | $5,000 | -99.8% | 1,574 | -99.8% | 0.00% | – |
| Q3 2018 | $2,342,000 | +425.1% | 890,526 | +486.7% | 0.00% | – |
| Q1 2018 | $446,000 | +7.2% | 151,780 | 0.0% | 0.00% | – |
| Q4 2017 | $416,000 | -19.2% | 151,780 | 0.0% | 0.00% | – |
| Q3 2017 | $515,000 | -62.2% | 151,780 | -72.5% | 0.00% | – |
| Q2 2017 | $1,362,000 | -35.8% | 551,469 | -41.0% | 0.00% | – |
| Q1 2017 | $2,120,000 | +7.1% | 934,050 | 0.0% | 0.00% | – |
| Q4 2016 | $1,980,000 | -27.7% | 934,050 | +14.3% | 0.00% | – |
| Q3 2016 | $2,738,000 | +7.4% | 817,350 | +0.7% | 0.00% | – |
| Q2 2016 | $2,550,000 | -5.7% | 812,000 | 0.0% | 0.00% | – |
| Q1 2016 | $2,704,000 | +2.3% | 812,000 | +8.7% | 0.00% | – |
| Q4 2015 | $2,644,000 | +40.9% | 746,900 | +100.2% | 0.00% | – |
| Q3 2015 | $1,876,000 | +39.8% | 373,004 | +78.8% | 0.00% | – |
| Q2 2015 | $1,342,000 | +13.0% | 208,673 | +23.5% | 0.00% | – |
| Q1 2015 | $1,188,000 | +100.0% | 168,923 | +119.4% | 0.00% | – |
| Q4 2014 | $594,000 | -11.6% | 77,000 | -14.4% | 0.00% | – |
| Q3 2014 | $672,000 | -79.7% | 90,000 | -73.7% | 0.00% | – |
| Q2 2014 | $3,317,000 | +10.8% | 342,621 | -4.9% | 0.00% | – |
| Q1 2014 | $2,993,000 | -71.8% | 360,121 | -71.4% | 0.00% | -100.0% |
| Q4 2013 | $10,625,000 | +5.9% | 1,258,921 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $10,034,000 | -79.6% | 1,258,921 | -80.2% | 0.00% | -75.0% |
| Q2 2013 | $49,204,000 | – | 6,373,539 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Chapters Capital Management LLC | 119,700 | $254,000 | 0.43% |
| GSA CAPITAL PARTNERS LLP | 1,587,756 | $3,366,000 | 0.20% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 60,901 | $129,110,000 | 0.14% |
| Acrospire Investment Management LLC | 129,480 | $274,000 | 0.11% |
| SECOR Capital Advisors, LP | 410,323 | $870,000 | 0.11% |
| RBF Capital, LLC | 251,421 | $540,000 | 0.08% |
| Park West Asset Management LLC | 400,000 | $848,000 | 0.07% |
| MACKENZIE FINANCIAL CORP | 4,687,825 | $9,938,000 | 0.06% |
| CIGNA INVESTMENTS INC /NEW | 261,533 | $554,000,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 5,503,285 | $11,665,000 | 0.06% |